Chen et al. found that the PI3K inhibitor LY294002 decreased tumor tumorigenicity in CRC stem cells by increasing production of the apoptosis-related protein cleaved caspase-3 [52]. This evidence concerns the gene CASP3 and colorectal carcinoma.